Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05304442 · ClinicalTrials.gov registry record · Phase 3
IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department
A Phase 3 study of Anemia, Iron Deficiency and Uterine Bleeding, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05304442 is a Phase 3 study of Anemia, Iron Deficiency and Uterine Bleeding that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 40 participants, below the 186-participant average among 8 other Anemia, Iron Deficiency trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05304442, a Phase 3 study of Anemia, Iron Deficiency and Uterine Bleeding, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this randomized trial is to assess the efficacy of IV Ferric Derisomaltose vs Oral Iron in the management of women with severe Iron Deficiency Anemia due to Uterine Bleeding in the emergency department.
Conditions Studied
Interventions
- DRUG Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric]
- DRUG Ferrous Sulfate 65 mg elemental iron (325 mg tablets)
Study Locations (1)
Texas
- Ben Taub Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-09-15 |
| Est. Completion | 2025-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05304442
The ClinicalTrials.gov registry entry for NCT05304442 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 186-participant average among 8 other Anemia, Iron Deficiency trials with a reported enrollment target (78% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anemia, Iron Deficiency appearing as the primary indexed condition, and to 2 interventions - of which Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric] is the first listed.
NCT05304442 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05304442 about?
NCT05304442 is a clinical study titled "IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department". The primary aim of this randomized trial is to assess the efficacy of IV Ferric Derisomaltose vs Oral Iron in the management of women with severe Iron Deficiency Anemia due to Uterine Bleeding in the emergency department.
What is the current status of trial NCT05304442?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2022-09-15. Estimated completion is 2025-04.
What conditions does trial NCT05304442 study?
This clinical trial studies the following conditions: Anemia, Iron Deficiency, Uterine Bleeding.
What interventions are being tested in trial NCT05304442?
The interventions under investigation include: Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric] (DRUG), Ferrous Sulfate 65 mg elemental iron (325 mg tablets) (DRUG).
Who is sponsoring clinical trial NCT05304442?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05304442 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia, Iron Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
COMPLETED · Phase 3
-
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
COMPLETED · Phase 3
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
Depth of Maximal Ileal Insertion During Retrograde Enteroscopy With TTS Balloon
RECRUITING
-
Heme and Non-heme Iron Intakes, Gut Microbiota, and Influence on Host Iron Absorption
RECRUITING
-
Iron Deficiency Anemia (IDA) and the Brain
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.